USPTO serial 79312860
LEADING PARTNER IN TIDES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BERTRAND, JOSEPH A
- Law office
- TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LEADING PARTNER IN TIDES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemical preparations for scientific purposes; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific purposes; reagents for chemical analyses; chemical preparations for scientific purposes, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemicals for industry; chemical reagents for scientific purposes; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; small molecules for use in industry and science; oligopeptides for industrial purposes; proteins for industrial purposes; oligonucleotides for industrial purposes; proteins for use in manufacture; oligonucleotides for use in manufacture; amino acids for industrial purposes; amino acids for scientific purposes; peptide substrates for scientific purposes; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; small molecules for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; small molecules for use in the manufacture of pharmaceuticals; chemical reagents for use in genetic research; chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of anti-diabetes drugs; active chemical ingredients for use in the manufacture of drugs against metabolic diseases; active chemical ingredients for use in the manufacture of drugs for wound healing; active chemical ingredients for use in the manufacture of drugs against genetic diseases; active chemical ingredients for use in the manufacture of drugs against neurologic diseases; amides for use in manufacture; chemical additives for use in manufacture; chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents for scientific or research purposes; diagnostic reagents, other than for medical or veterinary purposes; biological preparations for use in industry and science; biological preparations, other than for medical or veterinary purposes; adjuvants, other than for medical or veterinary purposes; biochemical catalysts; biochemical precursors for scientific purposes; biochemical preparations for scientific purposes; oligonucleotides for scientific purposes; proteins for scientific purposes; peptides for scientific purposes; biochemicals for in vitro and in vivo scientific purposes; emollients for industrial purposes; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceuticals; enzyme stabilizers; enzyme substrates; phosphoproteins | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; reagents for medical purposes; chemical preparations for medical purposes; peptides for medical purposes; proteins for medical purposes; oligonucleotides for medical purposes; small molecules for medical purposes; amino acids for medical purposes; chemical preparations for pharmaceutical purposes; peptides for pharmaceutical purposes; synthetic peptides for pharmaceutical purposes; proteins for pharmaceutical purposes; oligonucleotides for pharmaceutical purposes; small molecules for pharmaceutical purposes; chemical preparations for veterinary purposes; peptides for veterinary purposes; proteins for veterinary purposes; oligonucleotides for veterinary purposes; small molecules for veterinary purposes; amino acids for veterinary purposes; pharmaceutical preparations; pharmaceutical preparations containing amino acids; pharmaceutical substances; chemico-pharmaceutical preparations; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceutical and biological preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary purposes; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; small molecules for diagnostic purposes; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; chemical preparations for the diagnosis of pregnancy; biochemical preparations for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; biological preparations for diagnostic purposes; biological preparations for medical purposes; biological preparations for veterinary purposes; preparations against metabolic diseases; preparations for wound healing; preparations against genetic diseases; preparations against neurologic diseases; biological reagents for medical purposes; biological reagents for veterinary purposes; adjuvants for medical purposes; adjuvants for veterinary purposes; antibacterial preparations; anti-cancer preparations; antitumor drugs; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; anti-cancer preparations; anti-diabetic preparations; pharmaceutical preparations used in chemotherapy; clinical diagnostic reagents; cosmeceuticals for therapeutic or medical purposes; dermatological preparations; diagnostic biomarker reagents for medical purposes; dietary supplements with a cosmetic effect; dietetic substances adapted for medical purposes; dietetic substances adapted for veterinary purposes; drug delivery agents; injectable solutions for medical purposes; in vitro diagnostic preparations for medical purposes; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing | ACTIVE | — |
| 040 | Custom manufacturing; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacturing of peptides; custom manufacturing of proteins; custom manufacturing of oligonucleotides; custom manufacturing of small molecules; processing of materials; processing of chemicals; processing of chemical reagents; processing of peptides; processing of proteins; processing of oligonucleotides; processing of small molecules; processing of medicinal materials; processing of biopharmaceutical materials for others; refining services; treatment of materials; treatment of biopharmaceutical materials; treatment of materials upon request for third parties; treatment of materials for third parties | ACTIVE | — |
| 042 | Scientific research; chemical research; chemistry services; chemical engineering; product research and development; research and development of new products for others; industrial research, development and testing; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development in the field of small molecules; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of methods of manufacture; development of analytic methods; scientific laboratory services; chemical and biological laboratory services; scientific and industrial analysis and research services; laboratory research and analysis; chemical analysis; industrial analysis; analytical laboratory services; chemical, biochemical, biological and bacteriological research and analysis; analysis in the field of molecular biology; computer-aided scientific research, testing and analysis services; conducting of scientific studies; preparation of reports relating to scientific research; providing information about industrial analysis and research services; Quality control; product testing; evaluation of chemical analyses; evaluation of chemical syntheses; evaluation of product development; advisory services relating to material testing; consultancy in the field of biochemistry; consultancy in the field of chemistry; consultancy in the field of scientific and industrial research; consultancy relating to laboratory testing; consulting services in the field of recombinant DNA technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 4, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 16, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 7, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 7, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 7, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 26, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 11, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 10, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |